As a UK and European patent attorney, Nathan works with a broad range of clients, including academic institutions, university spin-outs, SMEs and multinational organisations. He has extensive experience of drafting and prosecuting patent applications in the UK and Europe, as well as coordinating the prosecution of his clients’ patent portfolios across the globe.
Nathan’s clients operate across a broad spectrum of chemical technologies, including membranes, polymers, glasses, ceramics, graphene, composite materials, catalysts, coatings, inks, adhesives, cosmetics, and pharmaceuticals formulations. Nathan also provides advice in relation to filing strategies, patentability and freedom-to-operate, and has a history of successes in representing clients at Oral Proceedings before the Examining Division, Opposition Division and Boards of Appeal of the European Patent Office.
First class honours (University of St Andrews, Scotland)
Intellectual Property Law (University of Manchester)
Intellectual Property Litigation Certificate
The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’. Such a refusal can …Read article
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.